| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.009 | 0.9 |